KNOXVILLE, Tenn. – Enigma Biomedical USA (EB) today announced a collaboration with Alamar Biosciences in the field of neurology. Through this collaboration, EB has a non-exclusive right to introduce Alamar’s protein detection and measurement technologies, including its ARGO™ HT instrument and NULISA™ reagent kits, to academic and pharma customers in the field of neurology research. […]
New CLIA-certified lab ensures seamless transition from early assay development and testing to full companion diagnostics commercialization SANTA CLARA, Calif. — Agilent Technologies Inc. , (NYSE: A) today announced the launch of its Biopharma CDx Services Lab (BCSL) in Carpinteria, California, following receipt of California State clinical laboratory license and Clinical Laboratory Improvement Amendments (CLIA) certificate of compliance. […]
Qkine is delighted to announce the appointment of Rob Nixon to its leadership team as Commercial Director and Paul Grafham as Chief Financial Officer. With years of experience working with fast-growing biotechs and life science reagent suppliers, these appointments will support the execution of the company’s growth strategies and expansion of its commercial operations globally. […]
DKSH has formed an exclusive partnership with Hygiena, a global leader in food safety and health diagnostics solutions, for their innovative diagnostic solutions. DKSH will leverage its market expansion services to enhance Hygiena’s presence in Cambodia, Laos, and Myanmar. Bangkok, Thailand – DKSH Business Unit Technology enters a new exclusive partnership with Hygiena, a prominent […]
Succeeds Dr. Stephen Schwartz Following 14-Year Tenure BURLINGTON, Mass. — Azenta, Inc. (Nasdaq: AZTA) (“Azenta” or “the Company”), today announced that John P. Marotta will join the Company as President and CEO effective September 9, 2024, succeeding Dr. Stephen Schwartz, who is retiring following a distinguished tenure. Dr. Schwartz will remain as an advisor to Azenta to ensure a smooth […]
BRANFORD, Conn. — Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that Liberate Bio, a Boston-based biotech unleashing the potential of genetic medicines with novel delivery vehicles, has integrated the Platinum® Next-Generation Protein Sequencer™ (“NGPS”) into their platform for developing novel gene therapies with improved targeting capabilities. Liberate […]
The new instrument enables high-throughput small and large molecule characterization in traditional and AI-driven workflows Salt Lake City, Utah – Carterra Inc., the world leader in innovative technologies enabling high-throughput biology, today has launched Carterra Ultra™—the latest addition to its LSA® and LSAXT label-free high-throughput surface plasmon resonance (HT-SPR) instruments. The Ultra platform enables small molecule applications […]
Christine Munz appointed as CEO Wilhelm Plüster completes term in office as planned Hamburg – The Supervisory Board of Eppendorf SE has appointed Dr. Christine Munz as the new CEO of the Eppendorf Group. On October 1, 2024, she will succeed Dr. Wilhelm Plüster who will now take on other strategically relevant responsibilities in the […]
Acquisition drives synergy within existing VION platform and creates greater opportunity to serve diagnostic market CHARLOTTESVILLE, Va. — VION Biosciences, a life science platform company focused on specialty materials in the life science research, diagnostic, and drug discovery spaces, announces its second acquisition this August with the acquisition of Ansh Labs, a biotechnology company that […]
Under a strategic partnership with Alamar Biosciences, Biognosys is a provider of choice of NULISA multiplex assay services for biopharma research The NULISAseq™ CNS Disease and Inflammation panels are now available for customers as a contract research service from Biognosys’ high-end proteomics facility in Europe By offering the combination of NULISA affinity-based assays and TrueDiscovery® mass […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
